Marta Vilar‐Villanueva

Marta Vilar‐Villanueva

Auto-generated profile, based on publicly available information

Marta Vilar‐Villanueva

Oral Medicine, Oral Surgery and Implantology Unit University of Santiago de Compostela Santiago de Compostela Spain

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2019 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
MVMarta Vilar‐Villanueva
Marta Vilar‐Villanueva
Pilar Gandara Gandara-VilaPilar Gandara Gandara-Vila
Pilar Gandara Gandara-Vila
EBElena Blanco-Aguilera
Elena Blanco-Aguilera
EOEva María Otero-Rey
Eva María Otero-Rey
LRLuis Rodríguez-Lado
Luis Rodríguez-Lado
ABAndrés Blanco-Carrión
Andrés Blanco-Carrión

23 August 2022 in Oral Diseases
Verified
Journal Article
Open access
MVMarta Vilar‐Villanueva
Marta Vilar‐Villanueva
JMJOSE MANUEL SOMOZA MARTÍN
JOSE MANUEL SOMOZA MARTÍN
ABAndrés Blanco-Carrión
Andrés Blanco-Carrión
AGAbel Garcia-Garcia
Abel Garcia-Garcia
TGTamara García‐Carnicero
Tamara García‐Carnicero
Pilar Gandara Gandara-VilaPilar Gandara Gandara-Vila
Pilar Gandara Gandara-Vila
Objectives: The main purpose of this study was to assess the response of oral leukoplakia to CO2 laser vaporization treatment, as well as determining possible factors that may affect recurrence of lesions.Materials and methods: A retrospective study was conducted, in which the medical records of patients who had been clinically and histologically diagnosed with oral leukoplakia and treated with CO2 laser between 1996 and 2019 at the Oral Medicine Teaching Unit of the Faculty of Dentistry of the University of Santiago de Compostela were reviewed.Results: Fifty‐eight patients were included: 36 female and 22 male subjects, with a mean age of 63.7 years old (SD ±13.1). The average follow‐up time was 57.5 months (SD ±57.9). A relapse rate of 52.6% was determined. Of all the studied variables, the margin was the only one for which a statistically significant association with recurrence of lesions was demonstrated (p < 0.05).Conclusion: The vaporization of lesions using CO2 laser with a safety margin of at least 3 mm from the clinical limits of OL is a key factor in preventing recurrence.

22 May 2024 in Oral Diseases
Verified
Journal Article
Closed access
MVMarta Vilar Villanueva
Marta Vilar Villanueva
JMJOSE MANUEL SOMOZA MARTÍN
JOSE MANUEL SOMOZA MARTÍN
ABAndrés Blanco-Carrión
Andrés Blanco-Carrión
AGAbel Garcia-Garcia
Abel Garcia-Garcia
TCTamara García Carnicero
Tamara García Carnicero
Pilar Gandara Gandara-VilaPilar Gandara Gandara-Vila
Pilar Gandara Gandara-Vila